Assessment of type I interferons, clinical signs and virus shedding in broiler chickens with pre and post challenge Newcastle disease vaccination

Document Type : Full paper (Original article)


1 Ph.D. Student in Avian Medicine, Department of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran

2 Department of Clinical Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran


Background: Newcastle disease (ND) causes devastating economic losses in poultry industry. Aims: This study evaluates the plausible effect of prior or post challenge vaccination with a live commercial vaccine on some pathogenic aspects of velogenic Newcastle disease virus (vNDV) infection in broilers with an emphasis on elucidating type I interferons (IFNs) response trends. Methods: Chicks (n=250) were randomly allocated into 5 equal groups including negative control (NC), positive control (PC) (challenged with vNDV), and treatment (T1-T3) groups: (T1) only received Villegas-Glisson/University of Georgia (VG/GA) strain of NDV vaccine, (T2) vaccinated 24 h prior to vNDV challenge, and (T3) vaccinated 24 h post vNDV challenge. Samples from trachea, cloacal content, and serum were collected at different time points to evaluate virus shedding or IFNs levels. Results: Although clinical signs and lesions were not completely blocked by administration of vaccine prior to or post vNDV inoculation, the disease severity diminished as demonstrated by an increase in bird’s survival rate and median survival days (MSDs). Moreover, prior to or post challenge VG/GA live vaccine administration, modified viral shedding patterns by decreasing the vNDV shedding period especially from the gastrointestinal (GI) system. Strong early type I IFNs response was observed in the trachea and sera of chickens vaccinated prior to or post-infection (pi) as compared to birds that received vaccine or vNDV alone. In trachea, IFN-α response was more pronounced than IFN-β, while both IFNs showed a considerable change in serum. Conclusion: It seems that vaccination after challenge with vNDV can improve bird’s health similar to prior administration and reduces virus shedding which may be due to type I IFNs production.


Main Subjects

Abdisa, T and Tagesu, T (2017). Review on Newcastle disease in poultry and its public health importance. J. Vet. Sci. Technol., 8(3).
Absalon, AE; Cortes-Espinosa, DV; Lucio, E; Miller, PJ and Afons, CL (2019). Epidemiology, control, and prevention of Newcastle disease in endemic regions: Latin America. Trop. Anim. Health Prod., 51: 1033-1048.
Ahmed, KA; Saxena, VK; Ara, A; Singh, KB; Sundaresan, NR; Saxena, M and Rasool, TJ (2007). Immune response to Newcastle disease virus in chicken lines divergently selected for cutaneous hypersensitivity. Int. J. Immunogenet., 34: 445-455.
Alexander, DJ; Aldous, EW and Fuller, CM (2012). The long view: a selective review of 40 years of Newcastle disease research. Avian Pathol., 41: 329-335.
Al-Garib, SO; Gielkens, AL; Gruys, DE; Hartog, L and Koch, G (2003). Immunoglobulin class distribution of systemic and mucosal antibody responses to Newcastle disease in chickens. Avian Dis., 47: 32-40.
Dimitrov, KM; Afonso, CL; Yu, Q and Miller, PJ (2017). Newcastle disease vaccines-A solved problem or a continuous challenge? Vet. Microbiol., 206: 126-136.
Ghalyanchilangeroudi, A; Hosseini, H; Jabbarifakhr, M; Fallah Mehrabadi, MH; Najafi, H; Ghafouri, SA; Mousavi, FS; Ziafati, Z and Modiri, A (2018). Emergence of a virulent genotype VIIi of Newcastle disease virus in Iran. Avian Pathol., 47: 509-519.
Kant, A; Koch, G; Van Roozelaar, DJ; Balk, F and Huurne, AT (1997). Differentiation of virulent and non-virulent strains of Newcastle disease virus within 24 hours by polymerase chain reaction. Avian Pathol., 26: 837-849.
Kapczynski, DR; Afonso, CL and Miller, PJ (2013). Immune responses of poultry to Newcastle disease virus. Dev. Comp. Immunol., 41: 447-453.
Karpala, AJ; Bingham, J; Schat, KA; Chen, LM; Donis, RO; Lowenthal, JW and Bean, AG (2011). Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper type 1 cytokine response in the chicken. J. Interferon Cytokine Res., 31: 393-400.
Li, X and Hanson, RP (1989). In vivo interference by Newcastle disease virus in chickens, the natural host of the virus. Arch. Virol., 108: 229-245.
Liu, WQ; Tian, MX; Wang, YP; Zhao, Y; Zou, NL; Zhao, FF; Cao, SJ; Wen, XT; Liu, P and Huang, Y (2012). The different expression of immune-related cytokine genes in response to velogenic and lentogenic Newcastle disease viruses infection in chicken peripheral blood. Mol. Biol. Rep., 39: 3611-3618.
Lomniczi, B (1973). Studies on interferon production and interferon sensitivity of different strains of Newcastle disease virus. J. Gen. Virol., 21: 305-313.
Mo, CW; Cao, YC and Lim, BL (2001). The in vivo and in vitro effects of chicken interferon alpha on infectious bursal disease virus and Newcastle disease virus infection. Avian Dis., 45: 389-399.
Munir, S; Sharma, JM and Kapur, V (2005). Transcriptional response of avian cells to infection with Newcastle disease virus. Virus Res., 107: 103-108.
Novak, R; Ester, K; Savic, V; Sekellick, MJ; Marcus, PI; Lowenthal, JW; Vainio, O and Ragland, WL (2001). Immune status assessment by abundance of IFN-alpha and IFN-gamma mRNA in chicken blood. J. Interferon Cytokine Res., 21: 643-651.
OIE (2012). Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. 7 Edn., Vol. 1, Paris, Biological Standards Commission.
Pei, J; Sekellick, MJ; Marcus, PI; Choi, IS and Collisson, EW (2001). Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness. J. Interferon Cytokine Res., 21: 1071-1077.
Penski, N; Hartle, S; Rubbenstroth, D; Krohmann, C; Ruggli, N; Schusser, B; Pfann, M; Reuter, A; Gohrbandt, S; Hundt, J; Veits, J; Breithaupt, A; Kochs, G; Stech, J; Summerfield, A; Vahlenkamp, T; Kaspers, B and Staeheli, P (2011). Highly pathogenic avian influenza viruses do not inhibit interferon synthesis in infected chickens but can override the interferon-induced antiviral state. J. Virol., 85: 7730-7741.
Perozo, F; Villegas, P; Dolz, R; Afonso, CL and Purvis, LB (2008). The VG/GA strain of Newcastle disease virus: mucosal immunity, protection against lethal challenge and molecular analysis. Avian Pathol., 37: 237-245.
Qu, H; Yang, L; Meng, S; Xu, L; Bi, Y; Jia, X; Li, J; Sun, L and Liu, W (2013). The differential antiviral activities of chicken interferon alpha (ChIFN-alpha) and ChIFN-beta are related to distinct interferon-stimulated gene expression. PLoS One. 8: e59307.
Reed, LJ and Muench, H (1938). A simple method of estimating fifty per cent endpoints 12. Am. J. Epidemiol., 27: 493-497.
Rue, C; Susta, L; Cornax, I; Brown, CC; Kapczynski, DR; Suarez,DL; King, DJ; Miller, P and Afonso, C (2011). Virulent Newcastle disease virus elicits a strong innate immune response in chickens. J. Gen. Virol., 92: 931-939.
Santhakumar, D; Rubbenstroth, D; Martinez-Sobrido, L and Munir, M (2017). Avian interferons and their antiviral effectors. Front Immunol., 8(49).
Sarcheshmei, M; Dadras, H; Mosleh, N and Mehrabanpour, M (2016). Comparative evaluation of the protective efficacy of different vaccination programs against a virulent field strain of the Newcastle disease virus
in broilers. Braz. J. Poult. Sci., 18: 363-370.
Sick, C; Schultz, U; Münster, U; Meier, J; Kaspers, B and Staeheli, P (1998). Promoter structures and differential responses to viral and nonviral inducers of chicken type I interferon genes. J. Biol. Chem., 273: 9749-9754.
Wajid, A; Basharat, A; Bibi, T and Rehmani, SF (2018). Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation. Trop. Anim. Health Prod., 50: 1645-1651.
Xia, C; Liu, J; Wu, ZG; Lin, CY and Wang, M (2004). The interferon-alpha genes from three chicken lines and its effects on H9N2 influenza viruses. Anim. Biotechnol., 15: 77-88.